Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000936392-00-000150
Filing Date
2000-03-27
Accepted
2000-03-27 00:00:00
Documents
8
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 YEAR ENDED DECEMBER 31, 1999 10-K405 196441
2 INSTRUMENTS DEFINING RIGHTS OF SECURITY HOLDERS EX-4.5 77244
3 EXHIBIT 10.44 EX-10.44 53625
4 EXHIBIT 10.45 EX-10.45 17230
5 EXHIBIT 10.46 EX-10.46 26945
6 EXHIBIT 10.47 EX-10.47 62920
7 CONSENT OF EXPERTS AND COUNSEL EX-23.1 948
8 FINANCIAL DATA SCHEDULE EX-27 2280
  Complete submission text file 0000936392-00-000150.txt   439771
Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-19700 | Film No.: 579976
SIC: 2834 Pharmaceutical Preparations